Global Codeine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Codeine is an opiate used to treat pain, coughing, and diarrhea. It is typically used to treat mild to moderate degrees of pain.

According to APO Research, The global Codeine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Codeine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Codeine include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma and Pharmaceutical Associates, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Codeine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Codeine, also provides the sales of main regions and countries. Of the upcoming market potential for Codeine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Codeine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Codeine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Codeine sales, projected growth trends, production technology, application and end-user industry.


Codeine Segment by Company

Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Mylan
Aristo Pharma GmbH
Lannett Company
Laboratoire Riva

Codeine Segment by Ingredient
Single-ingredient Codeine
Multi-ingredient Medications

Codeine Segment by Application

Narcotic Analgesic
Antitussive
Others

Codeine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Codeine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Codeine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Codeine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Codeine Market Size, 2020 VS 2024 VS 2031
1.3 Global Codeine Market Size Estimates and Forecasts (2020-2031)
1.4 Global Codeine Sales Estimates and Forecasts (2020-2031)
1.5 Global Codeine Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Codeine Market Dynamics
2.1 Codeine Industry Trends
2.2 Codeine Industry Drivers
2.3 Codeine Industry Opportunities and Challenges
2.4 Codeine Industry Restraints
3 Codeine Market by Manufacturers
3.1 Global Codeine Revenue by Manufacturers (2020-2025)
3.2 Global Codeine Sales by Manufacturers (2020-2025)
3.3 Global Codeine Average Sales Price by Manufacturers (2020-2025)
3.4 Global Codeine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Codeine Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Codeine Manufacturers, Product Type & Application
3.7 Global Codeine Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Codeine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Codeine Players Market Share by Revenue in 2024
3.8.3 2024 Codeine Tier 1, Tier 2, and Tier 3
4 Codeine Market by Type
4.1 Codeine Type Introduction
4.1.1 Single-ingredient Codeine
4.1.2 Multi-ingredient Medications
4.2 Global Codeine Sales by Type
4.2.1 Global Codeine Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Codeine Sales by Type (2020-2031)
4.2.3 Global Codeine Sales Market Share by Type (2020-2031)
4.3 Global Codeine Revenue by Type
4.3.1 Global Codeine Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Codeine Revenue by Type (2020-2031)
4.3.3 Global Codeine Revenue Market Share by Type (2020-2031)
5 Codeine Market by Application
5.1 Codeine Application Introduction
5.1.1 Narcotic Analgesic
5.1.2 Antitussive
5.1.3 Others
5.2 Global Codeine Sales by Application
5.2.1 Global Codeine Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Codeine Sales by Application (2020-2031)
5.2.3 Global Codeine Sales Market Share by Application (2020-2031)
5.3 Global Codeine Revenue by Application
5.3.1 Global Codeine Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Codeine Revenue by Application (2020-2031)
5.3.3 Global Codeine Revenue Market Share by Application (2020-2031)
6 Global Codeine Sales by Region
6.1 Global Codeine Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Codeine Sales by Region (2020-2031)
6.2.1 Global Codeine Sales by Region (2020-2025)
6.2.2 Global Codeine Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Codeine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Codeine Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Codeine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Codeine Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Codeine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Codeine Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Codeine Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Codeine Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Codeine Revenue by Region
7.1 Global Codeine Revenue by Region
7.1.1 Global Codeine Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Codeine Revenue by Region (2020-2025)
7.1.3 Global Codeine Revenue by Region (2026-2031)
7.1.4 Global Codeine Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Codeine Revenue (2020-2031)
7.2.2 North America Codeine Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Codeine Revenue (2020-2031)
7.3.2 Europe Codeine Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Codeine Revenue (2020-2031)
7.4.2 Asia-Pacific Codeine Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Codeine Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Codeine Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Taiji
8.1.1 Taiji Comapny Information
8.1.2 Taiji Business Overview
8.1.3 Taiji Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Taiji Codeine Product Portfolio
8.1.5 Taiji Recent Developments
8.2 Mallinckrodt
8.2.1 Mallinckrodt Comapny Information
8.2.2 Mallinckrodt Business Overview
8.2.3 Mallinckrodt Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Mallinckrodt Codeine Product Portfolio
8.2.5 Mallinckrodt Recent Developments
8.3 TEVA
8.3.1 TEVA Comapny Information
8.3.2 TEVA Business Overview
8.3.3 TEVA Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 TEVA Codeine Product Portfolio
8.3.5 TEVA Recent Developments
8.4 Johnson & Johnson
8.4.1 Johnson & Johnson Comapny Information
8.4.2 Johnson & Johnson Business Overview
8.4.3 Johnson & Johnson Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Johnson & Johnson Codeine Product Portfolio
8.4.5 Johnson & Johnson Recent Developments
8.5 Medreich
8.5.1 Medreich Comapny Information
8.5.2 Medreich Business Overview
8.5.3 Medreich Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Medreich Codeine Product Portfolio
8.5.5 Medreich Recent Developments
8.6 Sanofi Aventis
8.6.1 Sanofi Aventis Comapny Information
8.6.2 Sanofi Aventis Business Overview
8.6.3 Sanofi Aventis Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Sanofi Aventis Codeine Product Portfolio
8.6.5 Sanofi Aventis Recent Developments
8.7 Cipla
8.7.1 Cipla Comapny Information
8.7.2 Cipla Business Overview
8.7.3 Cipla Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Cipla Codeine Product Portfolio
8.7.5 Cipla Recent Developments
8.8 Hikma
8.8.1 Hikma Comapny Information
8.8.2 Hikma Business Overview
8.8.3 Hikma Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Hikma Codeine Product Portfolio
8.8.5 Hikma Recent Developments
8.9 Pharmaceutical Associates
8.9.1 Pharmaceutical Associates Comapny Information
8.9.2 Pharmaceutical Associates Business Overview
8.9.3 Pharmaceutical Associates Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Pharmaceutical Associates Codeine Product Portfolio
8.9.5 Pharmaceutical Associates Recent Developments
8.10 Novartis
8.10.1 Novartis Comapny Information
8.10.2 Novartis Business Overview
8.10.3 Novartis Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Novartis Codeine Product Portfolio
8.10.5 Novartis Recent Developments
8.11 Apotex
8.11.1 Apotex Comapny Information
8.11.2 Apotex Business Overview
8.11.3 Apotex Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Apotex Codeine Product Portfolio
8.11.5 Apotex Recent Developments
8.12 Mylan
8.12.1 Mylan Comapny Information
8.12.2 Mylan Business Overview
8.12.3 Mylan Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Mylan Codeine Product Portfolio
8.12.5 Mylan Recent Developments
8.13 Aristo Pharma GmbH
8.13.1 Aristo Pharma GmbH Comapny Information
8.13.2 Aristo Pharma GmbH Business Overview
8.13.3 Aristo Pharma GmbH Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Aristo Pharma GmbH Codeine Product Portfolio
8.13.5 Aristo Pharma GmbH Recent Developments
8.14 Lannett Company
8.14.1 Lannett Company Comapny Information
8.14.2 Lannett Company Business Overview
8.14.3 Lannett Company Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Lannett Company Codeine Product Portfolio
8.14.5 Lannett Company Recent Developments
8.15 Laboratoire Riva
8.15.1 Laboratoire Riva Comapny Information
8.15.2 Laboratoire Riva Business Overview
8.15.3 Laboratoire Riva Codeine Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Laboratoire Riva Codeine Product Portfolio
8.15.5 Laboratoire Riva Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Codeine Value Chain Analysis
9.1.1 Codeine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Codeine Production Mode & Process
9.2 Codeine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Codeine Distributors
9.2.3 Codeine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings